Amended Current Report Filing (8-k/a)
17 Marzo 2014 - 2:14PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K /A
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported)
: January
22, 2014
PLANDAÍ
BIOTECHNOLOGY, INC.
(Exact name of registrant as specified in its
charter)
Nevada
|
000-51206
|
20-1389815
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
2226 Eastlake Avenue East #156,
Seattle, WA
|
98102
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Registrant's telephone number, including area
code: (858) 461-0423
Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
SECTION 4 – MATTERS RELATED TO ACCOUNTANTS AND FINANCIALS
STATEMENTS
ITEM 4.01 CHANGES IN REGISTRANT’S CERTIFYING ACCOUNTANT
(a) On January 22, 2014, the Registrant accepted
the resignation of Patrick Rodgers, CPA, P.A. (“Rodgers”) from his engagement to be the independent certifying accountant
for the Registrant.
Effective March 6, 2014, the Public
Company Accounting Oversight Board ("PCAOB") revoked the registration of Patrick Rodgers, CPA, PA. due to Rogers’ violations
of PCAOB rules and auditing standards in auditing the financial statements and PCAOB rules and quality control standards with
respect to Rogers’ clients; the Registrant was not one of the clients for which Rogers was sanctioned. You can find a copy
of the order at http://pcaobus.org/Enforcement/Decisions/Documents/2014_Rodgers.pdf
Other than an explanatory paragraph
included in Rodgers’ audit report for the Registrant's fiscal years ended June 30, 2013 and 2012 relating to the
uncertainty of the Registrant's ability to continue as a going concern, the audit reports of Rodgers on the Registrant's financial
statements for the last fiscal year ended June 30, 2013 and 2012 through January 22, 2014, did not contain
an adverse opinion or a disclaimer of opinion, nor was it qualified or modified as to uncertainty, audit scope or
accounting principles.
During the Registrant's 2013 fiscal year
and through the date of this Current Report on Form 8-K, (1) there were no disagreements with Rodgers on any matter of accounting
principles or practices, financial statement disclosure, or auditing scope or procedure, which, if not resolved to the satisfaction
of Rodgers, would have caused Rodgers to make reference to the subject matter of the disagreements in connection with their report,
and (2) there were no “reportable events” as that term is defined in Item 304(a)(1)(v) of Regulation S-K.
(b) On January 22, 2014, the
Registrant’s Board of Directors approved the engagement of Terry L. Johnson, CPA, as the Registrant's independent accountant
effective immediately to audit the Registrant’s financial statements and to perform reviews of interim financial
statements. During the fiscal years ended June 30, 2013 and 2012 through January 22, 2014 neither
the Registrant nor anyone acting on its behalf consulted with Terry L. Johnson, CPA regarding (i) either the application of
any accounting principles to a specific completed or contemplated transaction of the Registrant, or the type of audit opinion
that might be rendered by Terry L. Johnson, CPA on the Registrant's financial statements; or (ii) any matter that was either
the subject of a disagreement with Rodgers or a reportable event with respect to Rodgers.
The Registrant provided Patrick Rodgers,
CPA, PA with an exhibit 16.1 letter to sign but the firm refused to sign the letter.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
Date:
March 17 , 2014
|
PLANDAÍ BIOTECHNOLOGY, INC.
|
|
|
|
By:
/s/ Roger Duffield
Roger Duffield, Chief Executive Officer
|
Plandai Biotechnology (PK) (USOTC:PLPL)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Plandai Biotechnology (PK) (USOTC:PLPL)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024
Real-Time news about Plandai Biotechnology Inc (PK) (OTCMarkets): 0 recent articles
Más de Plandai Biotechnology, Inc. Artículos de Noticias